Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 03, 2019
Catalent announced Guy J. Dewil, M.D. has been appointed General Manager of its clinical supply facility in Schorndorf, Germany.
read more
Thursday, October 03, 2019
Aldevron has added GMP gene synthesis to its array of services.
read more
Wednesday, October 02, 2019
Teva Pharmaceutical announced the retirement of Dr. Carlo de Notaristefani, and the appointment of Eric Drapé as Executive Vice President, Global Operations.
read more
Wednesday, October 02, 2019
LSNE announces approval of an ANDA from the FDA, for a sterile injectable product manufactured at their aseptic fill finish facility in León, Spain.
read more
Wednesday, October 02, 2019
Mednet and EMB Statistical Solutions (EMB) have entered a three-year agreement to provide a comprehensive suite of cloud-based eClinical services to EMB customers.
read more
Wednesday, October 02, 2019
Charles River announced the appointment of Virginia M. Wilson, the recently retired Senior Executive Vice President and Chief Financial Officer of TIAA, to its Board of Directors.
read more
Wednesday, October 02, 2019
Cellectis and Lonza announced the companies have entered into a manufacturing service agreement covering clinical manufacturing of Cellectis’ allogeneic UCART product candidates targeting hematological malignancies.
read more
Wednesday, October 02, 2019
AmerisourceBergen has been selected by Karyopharm Therapeutics to support XPOVIO™ (selinexor).
read more
Tuesday, October 01, 2019
N-SIDE announced AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials.
read more
Tuesday, October 01, 2019
Bioanalytical Systems announced the addition of Stewart B. Jacobson, DVM, DACVP, as Vice President, Pathology, effective October 1, 2019.
read more
Monday, September 30, 2019
Horizon Discovery Group announced the full commercial licensing to Glenmark of its gene-edited Glutamine Synthetase knockout Chinese Hamster Ovary K1 cell line.
read more
Monday, September 30, 2019
The FDA is announcing an award granting a new five-year contract for the Sentinel System, the FDA’s flagship active surveillance system.
read more
Monday, September 30, 2019
ASLAN and Bukwang announced they have established a new joint venture to develop preclinical aryl hydrocarbon receptor (AhR) antagonists from ASLAN’s early stage pipeline.
read more
Monday, September 30, 2019
MMS Holdings has collaborated with Oracle Health Sciences and a specialized Oncology pharmaceutical company.
read more
Monday, September 30, 2019
Teneobio announced one of the Janssen Companies has elected to exercise a commercial option to license and advance an undisclosed multispecific product for development in an oncology indication.
read more